All Comments by Richard C. Mohs

  1. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
  2. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
  3. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
  4. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
  5. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.
  6. Variations in the neuropathology of familial Alzheimer's disease.
  7. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.
  8. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
  9. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
  10. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
  11. Prevalence and implications of psychopathological non-cognitive symptoms in dementia.
  12. Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?